T. Rowe Price Investment Management, Inc. Abb Vie Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 18,731 shares of ABBV stock, worth $4.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,731
Previous 1,171,606
98.4%
Holding current value
$4.38 Million
Previous $217 Million
98.01%
% of portfolio
0.0%
Previous 0.14%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,485Shares Held
1.28BCall Options Held
17.1MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...